DaVita
DVA
#1450
Rank
$12.01 B
Marketcap
$150.22
Share price
-1.50%
Change (1 day)
8.82%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

Revenue for DaVita (DVA)

Revenue in 2024 (TTM): $12.81 Billion USD

According to DaVita's latest financial reports the company's current revenue (TTM ) is $12.81 Billion USD. an increase over the revenue in the year 2023 that were of $12.14 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for DaVita from 1996 to 2024

20002005201020152020$5B$10B$15Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 $12.81 B5.56%
2023 $12.14 B4.57%
2022 $11.60 B-0.08%
2021 $11.61 B0.59%
2020 $11.55 B1.42%
2019 $11.38 B-0.14%
2018 $11.40 B4.86%
2017 $10.87 B-20.77%
2016 $13.72 B-0.38%
2015 $13.78 B7.71%
2014 $12.79 B8.76%
2013 $11.76 B44.6%
2012 $8.13 B18.87%
2011 $6.84 B6.18%
2010 $6.44 B5.51%
2009 $6.10 B7.93%
2008 $5.66 B7.52%
2007 $5.26 B7.86%
2006 $4.88 B69.54%
2005 $2.87 B25.24%
2004 $2.29 B12.32%
2003 $2.04 B10.34%
2002 $1.85 B12.35%
2001 $1.65 B11.06%
2000 $1.48 B2.85%
1999 $1.44 B19.94%
1998 $1.20 B130.74%
1997 $0.52 B91.42%
1996 $0.27 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$20.66 B 61.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.01 B-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$15.82 B 23.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.00 B 1.51%๐Ÿ‡บ๐Ÿ‡ธ USA